d(GC) - Association of Biotechnology and Pharmacy
d(GC) - Association of Biotechnology and Pharmacy
d(GC) - Association of Biotechnology and Pharmacy
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Current Trends in <strong>Biotechnology</strong> <strong>and</strong> <strong>Pharmacy</strong><br />
Vol. 6 (2) 119-144 April 2012, ISSN 0973-8916 (Print), 2230-7303 (Online)<br />
<strong>of</strong> the protooncogene c-kit in peripheral<br />
blood mononuclear cells <strong>of</strong> patients who<br />
have mastocytosis with an associated<br />
hematologic disorder. Proc Natl Acad Sci<br />
U S A, 92: 10560-4.<br />
90. Kimura, A., Nakata, Y., Katoh, O., <strong>and</strong><br />
Hyodo, H. (1997). c-kit Point mutation in<br />
patients with myeloproliferative disorders.<br />
Leuk Lymphoma, 25: 281-7.<br />
91. Corless, C.L., Fletcher, J.A., <strong>and</strong> Heinrich,<br />
M.C. (2004). Biology <strong>of</strong> gastrointestinal<br />
stromal tumors. J Clin Oncol, 22: 3813-25.<br />
92. Maleddu, A., Pantaleo, M.A., Nannini, M.<br />
<strong>and</strong> Biasco, G. (2011). The role <strong>of</strong><br />
mutational analysis <strong>of</strong> KIT <strong>and</strong> PDGFRA in<br />
gastrointestinal stromal tumors in a clinical<br />
setting. Journal <strong>of</strong> Translational Medicine,<br />
9: 75-82.<br />
93. Heinrich, M.C., Corless, C.L., Demetri,<br />
G.D., Blanke, C.D., von Mehren, M.,<br />
Joensuu, H., McGreevey, L.S., Chen, C.J.,<br />
Van den Abbeele, A.D., Druker, B.J., Kiese,<br />
B., Eisenberg, B., Roberts, P.J., Singer, S.,<br />
Fletcher, C.D., Silberman, S., Dimitrijevic,<br />
S., <strong>and</strong> Fletcher, J.A. (2003). Kinase<br />
mutations <strong>and</strong> imatinib response in patients<br />
with metastatic gastrointestinal stromal<br />
tumor. J Clin Oncol, 21: 4342-9.<br />
94. Demetri, G.D., von Mehren, M., Blanke,<br />
C.D., Van den Abbeele, A.D., Eisenberg,<br />
B., Roberts, P.J., Heinrich, M.C., Tuveson,<br />
D.A., Singer, S., Janicek, M., Fletcher, J.A.,<br />
Silverman, S.G., Silberman, S.L.,<br />
Capdeville, R., Kiese, B., Peng, B.,<br />
Dimitrijevic, S., Druker, B.J., Corless, C.,<br />
Fletcher, C.D., <strong>and</strong> Joensuu, H. (2002).<br />
Efficacy <strong>and</strong> safety <strong>of</strong> imatinib mesylate in<br />
advanced gastrointestinal stromal tumors.<br />
N Engl J Med, 347: 472-80.<br />
95. Verweij, J., Casali, P.G., Zalcberg, J.,<br />
LeCesne, A., Reichardt, P., Blay, J.Y., Issels,<br />
R., van Oosterom, A., Hogendoorn, P.C.,<br />
Van Glabbeke, M., Bertulli, R., <strong>and</strong> Judson,<br />
I. (2004). Progression-free survival in<br />
Rebecca E. Smith <strong>and</strong> Juan Miguel Pascale<br />
142<br />
96.<br />
gastrointestinal stromal tumours with highdose<br />
imatinib: r<strong>and</strong>omised trial. Lancet,<br />
364: 1127-34.<br />
Agaram, N.P., Besmer, P., Wong, G.C.,<br />
Guo, T., Socci, N.D., Maki, R.G., DeSantis,<br />
D., Brennan, M.F., Singer, S., DeMatteo,<br />
R.P., <strong>and</strong> Antonescu, C.R. (2007).<br />
Pathologic <strong>and</strong> molecular heterogeneity in<br />
imatinib-stable or imatinib-responsive<br />
gastrointestinal stromal tumors. Clin<br />
Cancer Res, 13: 170-181.<br />
97. Heinrich, M.C., Corless, C.L., Blanke, C.D.,<br />
Demetri, G.D., Joensuu, H., Roberts, P.J.,<br />
Eisenberg, B.L., von Mehren, M., Fletcher,<br />
C.D., S<strong>and</strong>au, K., McDougall, K., Ou, W.B.,<br />
Chen, C.J., <strong>and</strong> Fletcher, J.A. (2006).<br />
Molecular correlates <strong>of</strong> imatinib resistance<br />
in gastrointestinal stromal tumors. J Clin<br />
Oncol, 24: 4764-74.<br />
98. Gounder, M.M. <strong>and</strong> Maki, R.G. (2011).<br />
Molecular basis for primary <strong>and</strong> secondary<br />
tyrosine kinase inhibitor resistance in<br />
gastrointestinal stromal tumor. Cancer<br />
Chemother Pharmacol, 67 Suppl 1: S25-<br />
43.<br />
99. Mendoza, Y., Singh, C., Mewa, J.C.,<br />
Fonseca, E., Smith, R. <strong>and</strong> Pascale, J.M.<br />
(2011). The beginning <strong>of</strong> personalized<br />
medicine in Panama: molecular <strong>and</strong><br />
pathological characteristics <strong>of</strong><br />
Gastrointestinal Stromal Tumors (GIST)<br />
from Archival Paraffin-embedded Tissue.<br />
Oncology Letters, 2: 941-947.<br />
100. Pao, W., Miller, V., Zakowski, M., Doherty,<br />
J., Politi, K., Sarkaria, I., Singh, B., Heelan,<br />
R., Rusch, V., Fulton, L., Mardis, E., Kupfer,<br />
D., Wilson, R., Kris, M., <strong>and</strong> Varmus, H.<br />
(2004). EGF receptor gene mutations are<br />
common in lung cancers from “never<br />
smokers” <strong>and</strong> are associated with<br />
sensitivity <strong>of</strong> tumors to gefitinib <strong>and</strong> erlotinib.<br />
Proc Natl Acad Sci U S A, 101: 13306-11.<br />
101. Derecskei, K., Moldvay, J., Bogos, K., <strong>and</strong><br />
Timar, J. (2006). Protocol modifications